Aurelio Maggio: The Mission and The Projects We Are Advancing for Rare Hematologic Diseases
Aurelio Maggio, President of Franco and Piera Cutino Foundation, shared on LinkedIn:
”Thalassemia is a rare blood disorder that still affects about 7,000 patients in Italy, many of whom depend on lifelong transfusions.
Research has changed the course of this disease in recent decades, but much remains to be done to prevent complications and move closer to a cure.
At the Franco and Piera Cutino Foundation we work every day on research, prevention and innovative therapies, from early prenatal diagnosis to gene therapy and international collaboration on rare hematologic diseases.
In this video I share the mission and the projects we are advancing, also supported by our Easter solidarity campaign ‘Giving makes you happy’.”
Stay updated with Hemostasis Today.
-
Sep 15, 2026, 08:13Salih Ehsan: Unraveling the Complex Phenotypes of TDT and NTDT
-
Sep 15, 2026, 07:52Tammuella Chrisentery-Singleton: Honored to Present at AHAD-AP Bangkok
-
Sep 15, 2026, 07:38Aaron Paul Kithcart: Connecting Science and Collaboration in Nagasaki
-
Sep 15, 2026, 02:59Caterina Casari: Curious about How Gene Editing is Revolutionizing Our Field?
-
Sep 15, 2026, 02:53Alejandro González Veliz: Can Lifestyle Changes Actually Reverse Atherosclerosis?
-
Sep 15, 2026, 02:08Eugenia Gianos: ACC CVPrevention Council’s New Statin Resources
-
Sep 15, 2026, 01:58Shinya Goto: Country Specific Randomized Trial Show the Merit of DOAC in Intermediate Risk of A
-
Sep 15, 2026, 01:37Lesley Van Wyk: Exploring Sickle Cell Disease – The HbS Story
-
Sep 15, 2026, 01:31Luca Seffin: To the Science, the People, and the Journey – Thank You SR-Tiget